Source: Journal of Viral Hepatitis. Unidade: IB
Subjects: HEPATITE C, GENÓTIPOS
ABNT
QUEIRÓZ, Artur Trancoso Lopo de et al. Relation of pretreatment sequence diversity in NS5A region of HCV genotype 1 with immune response between pegylated- INF / ribavirin therapy outcomes. Journal of Viral Hepatitis, v. 18, n. 2, p. 142-148, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2893.2010.01294.x. Acesso em: 11 nov. 2024.APA
Queiróz, A. T. L. de, Maracaja-Coutinho, V. R. H., Jardim, A. C. G., Rahal, P., Carvalho-Mello, I. M. V. G. de, & Matioli, S. R. (2011). Relation of pretreatment sequence diversity in NS5A region of HCV genotype 1 with immune response between pegylated- INF / ribavirin therapy outcomes. Journal of Viral Hepatitis, 18( 2), 142-148. doi:10.1111/j.1365-2893.2010.01294.xNLM
Queiróz ATL de, Maracaja-Coutinho VRH, Jardim ACG, Rahal P, Carvalho-Mello IMVG de, Matioli SR. Relation of pretreatment sequence diversity in NS5A region of HCV genotype 1 with immune response between pegylated- INF / ribavirin therapy outcomes [Internet]. Journal of Viral Hepatitis. 2011 ; 18( 2): 142-148.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/j.1365-2893.2010.01294.xVancouver
Queiróz ATL de, Maracaja-Coutinho VRH, Jardim ACG, Rahal P, Carvalho-Mello IMVG de, Matioli SR. Relation of pretreatment sequence diversity in NS5A region of HCV genotype 1 with immune response between pegylated- INF / ribavirin therapy outcomes [Internet]. Journal of Viral Hepatitis. 2011 ; 18( 2): 142-148.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/j.1365-2893.2010.01294.x